NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-178-2014-2-FR-08 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE FR EP 15766697.5 Issued
NIAID E-178-2014-2-PCT-01 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE PCT PCT COMB PCT/US2015/048729 Expired
NIAID E-076-2015-4-CA-05 VACCINE COMBINATION INCLUDING VECTORS COMPRISING NUCLEIC ACID ENCODING ANTIGENS FROM FILOVIRUS SUBTYPES CA National Stage 2960092 Issued
NIAID E-076-2015-4-AU-03 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION AU National Stage 2015311852 Issued
NIAID E-076-2015-5-AU-03 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES AU National Stage 2015311868 Issued
NIAID E-076-2015-4-JP-12 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION JP National Stage 2017-512990 Issued
NIAID E-076-2015-5-NG-22 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES NG National Stage F/P/2017/122 Issued
NIDA E-073-2013-0-US-06 POTENT AND SELECTIVE INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF US National Stage 14/772,486 9862679 Issued PDF
NIAID E-076-2015-5-PCT-01 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES PCT PCT COMB PCT/US2015/048388 Expired
NIAID E-076-2015-4-PCT-01 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION PCT PCT COMB PCT/US15/048357 Expired
NIAID E-076-2015-5-EP-08 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES EP National Stage 15771771.1 Abandoned
NIAID E-076-2015-4-EP-08 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION EP National Stage 15767631.3 Issued
NIAID E-076-2015-5-JP-23 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES JP DIV 2019-063057 Pending
NIAID E-076-2015-5-JP-12 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES JP National Stage 2017-512836 Pending
NIAID E-076-2015-5-MY-15 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES MY National Stage PI 2017700702 Abandoned
NIAID E-076-2015-4-NZ-16 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION NZ National Stage 2073-05-11 Pending
NIAID E-076-2015-5-NZ-16 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES NZ National Stage 2073-05-20 Abandoned
NIAID E-076-2015-5-KR-13 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES KR National Stage 10-2017-7008912 Pending
NIAID E-076-2015-5-SG-18 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES SG National Stage 11201701745T Pending
NIAID E-076-2015-4-SG-18 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION SG National Stage 11201701741Q Pending
NIAID E-076-2015-5-ZA-21 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES ZA National Stage 2017/01813 Pending
NIAID E-076-2015-5-OA-17 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES OA National Stage 120170076 Pending
NIAID E-076-2015-5-EA-07 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES EA National Stage 210790507 Abandoned
NIAID E-076-2015-5-AP-02 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES AP National Stage AP/P/2017/009822 Pending
NIAID E-076-2015-5-BR-04 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES BR National Stage BR1120170042029 Pending
NIAID E-076-2015-5-CN-06 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES CN National Stage 201580055345.X Pending
NIAID E-076-2015-5-CA-05 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES CA National Stage 2960096 Abandoned
NIAID E-076-2015-4-UA-19 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION UA National Stage a 2017 03034 Pending
NIAID E-076-2015-5-UA-19 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES UA National Stage a 2017 02986 Abandoned
NIAID E-076-2015-5-IN-11 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES IN National Stage 201717010988 Pending
NIAID E-076-2015-5-HK-09 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES HK National Stage 17113099.4 Abandoned
NIAID E-076-2015-4-IN-11 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION IN National Stage 201717011032 Pending
NIAID E-076-2015-5-IL-10 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES IL National Stage 2018-08-25 Pending
NCI E-059-2013-0-JP-07 Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor JP National Stage 2015-560159 Issued
NHLBI E-165-2012-0-US-04 Direct Pressure-mediated Intrabone Delivery System For Cellular Therapeutics US National Stage 14/772,044 Abandoned
NCI E-085-2013-0-US-06 METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM PERIPHERAL BLOOD US National Stage 14/771,593 9844569 Issued PDF
NCI E-059-2013-0-US-09 METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM TUMOR US National Stage 14/771,615 Abandoned
NCI E-257-2014-0-PCT-02 Immunogenic Modulation By Endocrine Deprivation Therapy Improves Sensitivity Of Tumor Cells To Immune Mediated Lysis PCT PCT PCT/US15/047538 Expired
NEI E-164-2014-0-EP-05 Methods and Compositions for Treating Leber Congenital Amaurosis EP National Stage 15760025.5 Issued
NEI E-164-2014-0-GB-09 Methods and Compositions for Treating Leber Congenital Amaurosis GB EP 15760025.5 Issued
NEI E-164-2014-0-FR-07 Methods and Compositions for Treating Leber Congenital Amaurosis FR EP 15760025.5 Issued
NEI E-164-2014-0-DE-08 Methods and Compositions for Treating Leber Congenital Amaurosis DE EP 15760025.5 Issued
NEI E-164-2014-0-CA-04 Methods and Compositions for Treating Leber Congenital Amaurosis CA National Stage 2959540 Issued
NIAID E-018-2010-0-US-10 Recombinant Modified Vaccina Ankara (MVA) Vaccina Virus Containing Restructured Insertion Sites US DIV 14/837,382 9879231 Issued PDF
NCI E-130-2011-0-US-06 Human Monoclonal Antibodies Specific for Glypican-3 and Uses Thereof US DIV 14/837,903 9394364 Issued PDF
NEI E-164-2014-0-PCT-02 Methods and Compositions for Treating Leber Congenital Amaurosis PCT PCT PCT/US2015/047209 Expired
NIAID E-337-2004-0-JP-23 Recombinant MVA Viruses Expressing Clade A/G, Clade B, and C Modified HIV Env, Gag, And Pol Genes JP DIV 2012-180606 Abandoned
NIAID E-248-2006-0-US-19 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus US DIV 14/833,913 10421978 Issued PDF
NIDA E-199-2015-0-PCT-03 Method and Apparatus for the Capture of Intra-cellular Activity PCT PCT PCT/US2015/046576 Expired
NIDA E-199-2015-0-US-02 Method And Apparatus For The Capture Of Intra-cellular Activity US ORD 14/834,334 Abandoned